• HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
    • My account
    • Cart
  • CONTACT
ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting
Share
News

ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting

November 26, 2018
-
Posted by David Ribeiro

The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed at the Winter meeting of the British Thoracic Society, which takes place between December 5th-7th at the Queen Elizabeth II Conference Centre, in London. Details of the abstract accepted by the conference review committee are detailed below:

P111: Quantification of Active Proteinase 3 in Sputum Samples Using a Novel Activity-Based Immunoassay

Presenting author: Dr Timothy Ferguson

Session – Understanding complications of cystic fibrosis

Thursday 6th December

 

Dr David Ribeiro, CEO of ProAxsis, said: “The ProteaseTag® Active Proteinase 3 Immunoassay was recently registered with a European CE Mark, and ProAxsis are delighted to be sharing data on this exciting new addition to the company’s portfolio of immunoassays.”

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.

To find out how ProAxsis can support the measurement of active protease biomarkers of disease, or for any further queries, please contact info@proaxsis.com

November 26, 2018

Related News

Other posts that you should not miss.
News

ProAxsis builds market presence

June 20, 2016
-
Posted by Webmaster

ProAxsis (www.proaxsis.com) is undertaking business development activities with Invest Northern Ireland support. Speaking about the plans, Dr David …

Read More
June 20, 2016
Posted by Webmaster
Neutrophil Elastase Immunoassay, News, ProteaseTag®

ProteaseTag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis

December 23, 2016
-
Posted by Webmaster

In a significant new study, a team at the University of Dundee has shown for the first time that sputum …

Read More
December 23, 2016
Posted by Webmaster
News, ProteaseTag®

ProAxsis receives Royal visit

October 19, 2016
-
Posted by Webmaster

ProAxsis were this week delighted to host His Royal Highness, the Duke of York, at their new laboratory …

Read More
October 19, 2016
Posted by Webmaster
← PREVIOUS POST
New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases
NEXT POST →
ProAxsis assays selected for inclusion in major new ERS-funded study
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis supports next generation of scientists
    October 25, 2019

    ProAxsis was delighted to support the recent School of Pharmacy Undergraduate Awards at Queen’s …

  • ProAxsis welcomes Professor Stephen Smith as new Chairman
    October 25, 2019

    ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman …

  • New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases
    June 3, 2019

    Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • November 18, 2019
    ProAxsis shortlisted for Small Business of the Year Award
  • October 25, 2019
    ProAxsis supports next generation of scientists
  • October 25, 2019
    ProAxsis welcomes Professor Stephen Smith as new Chairman
LATEST TWEETS
Twitter
ProAxsis
Follow Me
@TimFerguson01 https://t.co/00k2mJHY4o
16 days ago
- ProAxsis
Having a great night and delighted to be shortlisted at the #AIBBEawards @eye_business
16 days ago
- ProAxsis
RT @geinarsson: Recommended preprint by Alison Dicker et al. from @ProfJDChalmers group in Dundee on "The Sputum Microbiome Is Associated w…
33 days ago
- ProAxsis
RT @ProfJDChalmers: In summary- lower microbiome diversity means more exacerbations, more lung inflammation and a higher risk of mortality…
33 days ago
- ProAxsis
Copyright © 2016-2018 - ProAxsis - All rights reserved. 
ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting | ProAxsis